Email Alert | RSS    帮助

中国防痨杂志 ›› 2023, Vol. 45 ›› Issue (12): 1147-1151.doi: 10.19982/j.issn.1000-6621.20230364

• 论著 • 上一篇    下一篇

新型化合物舒达吡啶(WX-081)对脓肿分枝杆菌的抗菌活性

苏雷1, 刘丽娜2, 王庆枫3, 初乃惠3(), 聂文娟3()   

  1. 1河南省安阳市结核病防治所住院一病区,安阳 455000
    2河北省衡水市第三人民医院呼吸与危重症医学科三病区,衡水 053000
    3首都医科大学附属北京胸科医院结核一科,北京 101149
  • 收稿日期:2023-10-15 出版日期:2023-12-10 发布日期:2023-11-27
  • 通信作者: 聂文娟,Email:94642975@qq.com;初乃惠,Email:dongchu1994@sina.com
  • 作者简介:注:刘丽娜和苏雷对本文有同等贡献,为并列第一作者
  • 基金资助:
    国家自然科学基金(82100002);北京市卫生健康委员会卫生健康科技成果和适宜技术课题(BHTPP2022083)

Antibacterial activity of a new compound, Shudapyridine (WX-081), against Mycobacterium abscesses

Su Lei1, Liu Lina2, Wang Qingfeng3, Chu Naihui3(), Nie Wenjuan3()   

  1. 1Inpatient Ward Ⅰ, Tuberculosis Prevention and Control Institute of Anyang City, Henan Province, Anyang 455000, China
    2Inpatient Ward Ⅲ, Respiratory and Critical Care Medicine Department, Third People’s Hospital of Hengshui City, Hebei Province, Hengshui 053000, China
    3Tuberculosis Department Ⅰ, Beijing Chest Hospital, Capital Medical University, Beijing 101149, China
  • Received:2023-10-15 Online:2023-12-10 Published:2023-11-27
  • Contact: Nie Wenjuan, Email: 94642975@qq.com; Chu Naihui, Email: dongchu1994@sina.com
  • Supported by:
    National Natural Science Foundation of China(82100002);Health Science and Technology Achievements and Appropriate Technologies Project of Beijing Municipal Health Commission(BHTPP2022083)

摘要:

目的: 分析舒达吡啶(WX-081)抗脓肿分枝杆菌的体外及体内活性。方法: 选取脓肿分枝杆菌标准株ATCC19977和7株脓肿分枝杆菌临床分离株,进行WX-081对脓肿分枝杆菌最低抑菌浓度(minimal inhibitory concentration,MIC)测定。为了进一步评价WX-081对脓肿分枝杆菌体内活性,选取AB型野生斑马鱼,构建脓肿分枝杆菌感染斑马鱼模型,对WX-081、贝达喹啉和阿奇霉素进行最大耐受浓度(maximum talerated concentration,MTC)检测,评估WX-081对脓肿分枝杆菌的抑菌效果。结果: WX-081对1株脓肿分枝杆菌标准株和7株临床分离株的体外MIC范围为0.7813~1.5625μg/ml。斑马鱼对阿奇霉素、贝达喹啉和WX-081的MTC分别为62.50μg/ml、15.60μg/ml和62.50μg/ml。WX-081浓度为11.95μg/ml、3.91μg/ml、7.81μg/ml、15.60μg/ml、31.20μg/ml、62.50μg/ml时斑马鱼全身荧光强度分别为535952±23902、520519±18208、492988±17182、462296±14360、419947±13302、375347±11359;斑马鱼头部荧光强度分别为101579±6065、101495±10160、93190±5468、89877±10333、76778±4906、70976±5726;随WX-081浓度升高逐渐下降,且均分别明显低于未用药的感染动物模型组(斑马鱼全身荧光强度为671089±22305;斑马鱼头部荧光强度为671089±22305),差异均有统计学意义(斑马鱼全身荧光强度比较:t值分别为4.134、5.229、6.326、7.871、9.670、11.815,P值均<0.001;斑马鱼头部荧光强度比较:t值分别为2.639、2.170、3.444、2.872、4.999、5.336,P值均<0.001)。斑马鱼受精后第4~9天,WX-081浓度为1.95μg/ml、3.91μg/ml和7.81μg/ml时,斑马鱼死亡率分别为90.0%(54/60)、85.0%(51/60)和81.7%(49/60),随着WX-081浓度逐渐升高死亡率逐渐下降(P<0.05)。结论: WX-081有效抑制了脓肿分枝杆菌在体外和体内的生长,延长了感染脓肿分枝杆菌斑马鱼的存活时间,显示出其对脓肿分枝杆菌较好的抗菌活性。

关键词: 非典型性细菌, 分枝杆菌感染, 抗菌药, 舒达吡啶(WX-081)

Abstract:

Objective: To analyze the in vitro and in vivo activity of Sudapyridine (WX-081) against Mycobacterium abscess. Methods: The standard strain ATCC19977 and 7 clinical isolates of Mycobacterium abscess were selected, and the minimum inhibitory concentration (MIC) of WX-081 against Mycobacterium abscess were measured. In order to further evaluate the in vivo activity of WX-081 against Mycobacterium abscesses, AB type wild zebrafish was selected to construct an infection model of Mycobacterium abscesses. The maximum tolerated concentration (MTC) of WX-081, betaquiline, and azithromycin were tested to evaluate the antibacterial effect of WX-081 against Mycobacterium abscesses. Results: The in vitro MIC range of WX-081 for 1 standard strain of Mycobacterium abscess and 7 clinical isolates was 0.7813-1.5625 μg/ml. The MTCs of zebrafish against azithromycin, betaquiline, and WX-081 were 62.50 μg/ml, 15.60 μg/ml, and 62.50 μg/ml, respectively. When the concentrations of WX-081 were 11.95 μg/ml, 3.91 μg/ml, 7.81 μg/ml, 15.60 μg/ml, 31.20 μg/ml, and 62.50 μg/ml, the whole body fluorescence intensities of zebrafish were 535952±23902, 520519±18208, 492988±17182, 462296±14360, 419947±13302, and 375347±11359, respectively; the fluorescence intensities of zebrafish head were 101579±6065, 101495±10160, 93190±5468, 89877±10333, 76778±4906, and 70976±5726, respectively; with the increase of WX-081 concentration, the values gradually decreased and were lower than those of the untreated infected animal model group (zebrafish whole body fluorescence intensity was 671089±22305; zebrafish head fluorescence intensity was 671089±22305, the differences were statistically significant (comparison of whole body fluorescence intensity of zebrafish: t values were 4.134, 5.229, 6.326, 7.871, 9.670, and 11.815, respectively, all P<0.001; comparison of head fluorescence intensity of zebrafish: t values were 2.639, 2.170, 3.444, 2.872, 4.999, and 5.336, respectively, all P<0.001). On the 4th to 9th day after fertilization, when the WX-081 concentrations of 1.95 μg/ml, 3.91 μg/ml and 7.81 μg/ml, the mortality rates of zebrafish were 90.0% (54/60), 85.0% (51/60), and 81.7% (49/60), respectively. When the concentration of WX-081 gradually increased, the mortality rate gradually decreased (P<0.05). Conclusion: WX-081 effectively inhibits the growth of Mycobacterium abscesses in vitro and in vivo, prolongs the survival time of zebrafish infected with Mycobacterium abscesses, and it has good activity against Mycobacterium abscesses.

Key words: Atypical bacterial forms, Mycobacterium infections, Anti-bacterial agents, Sudapyridine (WX-081)

中图分类号: